BCR/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair

被引:79
作者
Cramer, Kimberly [1 ,2 ]
Nieborowska-Skorska, Margaret [1 ]
Koptyra, Mateusz [1 ]
Slupianek, Artur [1 ]
Penserga, Emir Tyrone P. [1 ]
Eaves, Connie J. [3 ]
Aulitzky, Walter [4 ]
Skorski, Tomasz [1 ]
机构
[1] Temple Univ, Sch Med, Dept Microbiol & Immunol, MRB, Philadelphia, PA 19140 USA
[2] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA
[3] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
[4] Robert Bosch Krankenhaus, Dept Internal Med Oncol & Hematol 2, Stuttgart, Germany
关键词
D O I
10.1158/0008-5472.CAN-08-1101
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Myeloproliferative disorders (MPD) are stem cell-derived clonal diseases arising as a consequence of acquired aberrations in c-ABL, Janus-activated kinase 2 (JAK2), and platelet-derived growth factor receptor (PDGFR) that generate oncogenic fusion tyrosine kinases (FTK), including BCR/ABL, TEL/ABL, TEL/JAK2, and TEL/PDGF beta R. Here, we show that FTKs stimulate the formation of reactive oxygen species and DNA double-strand breaks (DSB) both in hematopoietic cell lines and in CD34(+) leukemic stem/progenitor cells from patients with chronic myelogenous leukemia (CML). Single-strand annealing (SSA) represents a relatively rare])of. very unfaithful DSB repair mechanism causing chromosomal aberrations. Using a specific reporter cassette integrated into genomic DNA, we found that BCR/ABL, and other FTKs stimulated SSA activity. Imatinib-mediated inhibition of BCR/ABL abrogated this effect, implicating a kinase-dependent mechanism. Y253F, F255K, T3151, and 14396P mutants of BCR/ABL that confer imatinib resistance also stimulated SSA. Increased expression of either nonmutated or mutated BCR/ABL kinase, as is typical of blast phase cells and very primitive chronic phase CML cells, was associated with higher SSA activity. BCR/ABL-mediated stimulation of SSA was accompanied by enhanced nuclear colocalization of RAD52 and ERCC1, which play it key role in the repair. Taken together, these findings suggest a role of FTKs in causing disease progression in MPDs by inducing chromosomal instability through the production of DSBs and stimulation of SSA repair.
引用
收藏
页码:6884 / 6888
页数:5
相关论文
共 20 条
[1]   Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression [J].
Bacher, U ;
Haferlach, T ;
Hiddemann, W ;
Schnittger, S ;
Kern, W ;
Schoch, C .
CANCER GENETICS AND CYTOGENETICS, 2005, 157 (01) :53-61
[2]   Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction [J].
Copland, Mhairi ;
Hamilton, Ashley ;
EIrick, Lucy J. ;
Baird, Janet W. ;
Allan, Elaine K. ;
Jordanides, Niove ;
Barow, Martin ;
Mountford, Joanne C. ;
Holyoake, Tessa L. .
BLOOD, 2006, 107 (11) :4532-4539
[3]   Chromosomal translocation mechanisms at intronic Alu elements in mammalian cells [J].
Elliott, B ;
Richardson, C ;
Jasin, M .
MOLECULAR CELL, 2005, 17 (06) :885-894
[4]   PROGNOSTIC FACTORS IN ADULT CHRONIC MYELOMONOCYTIC LEUKEMIA - AN ANALYSIS OF 107 CASES [J].
FENAUX, P ;
BEUSCART, R ;
LAI, JL ;
JOUET, JP ;
BAUTERS, F .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (09) :1417-1424
[5]   Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib [J].
Griswold, Ian J. ;
MacPartlin, Mary ;
Bumm, Thomas ;
Goss, Valerie L. ;
O'Hare, Thomas ;
Lee, Kimberly A. ;
Corbin, Amie S. ;
Stoffregen, Eric P. ;
Smith, Caitlyn ;
Johnson, Kara ;
Moseson, Erika M. ;
Wood, Lisa J. ;
Polakiewicz, Roberto D. ;
Druker, Brian J. ;
Deininger, Michael W. .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (16) :6082-6093
[6]   Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia [J].
Hernández, JM ;
del Cañizo, MC ;
Cuneo, A ;
García, JL ;
Gutiérrez, NC ;
González, M ;
Castoldi, G ;
San Miguel, JF .
ANNALS OF ONCOLOGY, 2000, 11 (04) :441-444
[7]   Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis [J].
Kolomietz, E ;
Al-Maghrabi, J ;
Brennan, S ;
Karaskova, J ;
Minkin, S ;
Lipton, J ;
Squire, JA .
BLOOD, 2001, 97 (11) :3581-3588
[8]   BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance [J].
Koptyra, Mateusz ;
Falinski, Rafal ;
Nowicki, Michal O. ;
Stoklosa, Tomasz ;
Majsterek, Ireneusz ;
Nieborowska-Skorska, Margaret ;
Blasiak, Janusz ;
Skorski, Tomasz .
BLOOD, 2006, 108 (01) :319-327
[9]   Physical and functional interaction between the XPF/ERCC1 endonuclease and hRad52 [J].
Motycka, TA ;
Bessho, T ;
Post, SM ;
Sung, P ;
Tomkinson, AE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (14) :13634-13639
[10]   The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein [J].
Neviani, P ;
Santhanam, R ;
Trotta, R ;
Notari, M ;
Blaser, BW ;
Liu, SJ ;
Mao, H ;
Chang, JS ;
Galietta, A ;
Uttam, A ;
Roy, DC ;
Valtieri, M ;
Bruner-Klisovic, R ;
Caligiuri, MA ;
Bloomfield, CD ;
Marcucci, G ;
Perrotti, D .
CANCER CELL, 2005, 8 (05) :355-368